The message is clear and important. There are simple tests to diagnose familial hypercholesterolemia (FH); and effective, affordable treatments to lower LDL cholesterol to stop early heart disease and stroke. But today, only about 15 to 20% of people with FH are being diagnosed and some of them are … Read More →
It was 2010 and I was 36 years old. I was living in Texas at the time, enjoying my career at Motorola. When I wasn’t working, I was bass fishing on Lake Austin, recording music and having cook-outs with our neighbors. Most of all, I was enjoying spending time with my two active young boys. Life … Read More →
PASADENA, Calif., May 26, 2021 – Individuals with genetic high cholesterol, heart disease or both, who were infected with COVID-19 had more heart attacks according to new research by the FH Foundation. While previous studies have speculated about poorer outcomes if a person with genetic high … Read More →
A strategic imperative of the FH Foundation is to increase FH diagnosis and improve the rate of cascade screening. We began this work in 2013 with the establishment of the CASCADE FH Registry (CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia Registry) and continue today. … Read More →
Healthcare systems around the world have failed to rescue individuals born with Familial Hypercholesterolemia (FH), even though we have had life-saving therapies for the last 34 years. Without the societal commitment to screen, diagnose, and manage FH, the opportunity to prevent heart disease and … Read More →
How learnings from COVID-19 can be applied to understanding the most destructive pandemic in human history: heart disease.
What is the impact of early diagnosis and appropriate treatment on disease management and longevity for individuals with familial hypercholesterolemia (FH) over the course of 45 years?
I answered this and many other questions in this research letter titled “Life by the Numbers: Living with Familial … Read More →
Large-scale research and genetic studies concur that familial hypercholesterolemia (FH) is a common genetic condition that impacts all races and ethnicities. In fact, it is estimated that 1 in 250 individuals worldwide have FH. That means, each of us reading this FH Foundation blog probably knows … Read More →
Lipoprotein(a), or Lp(a), is an important genetic risk factor for heart attacks and strokes. Many are unaware of what Lp(a) is or know that they should request for it to be tested. The FH Foundation is hosting a Lp(a) 101 webinar featuring Dr Mary McGowan, Chief Medical Officer of the … Read More →
Katherine Wilemon, founder and CEO of the FH Foundation, recently authored a paper with researchers from Stanford University that highlighted key differences in care for women with familial hypercholesterolemia (FH). The paper published in Current Atherosclerosis Reports highlights the unique needs … Read More →
